To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of health software, and for other purposes.
Sensible Oversight for Technology which Advances Regulatory Efficiency Act or the SOFTWARE Act
This bill amends the Federal Food, Drug, and Cosmetic Act to define health software as software that does not acquire, process, or analyze data from an in vitro diagnostic device or signal acquisition system, is not an accessory or part of a medical device, is not used to prevent disease in the transfusion of blood and blood components, and is for:
The FDA must classify an accessory of a medical device independently from the medical device with which it is used.
Health software is exempted from regulation by the FDA (including as a medical device), except for software that provides patient-specific recommendations and poses a significant risk to patient safety.
The FDA must review existing regulations and guidance regarding the regulation of health software.Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line